Stay up-to-date with our latest news and company announcements.

May 2, 2022

Patient Square Capital Announces the Formation of Enavate Sciences to Invest in and Support Therapeutic Companies

James Boylan, Accomplished Health Care Executive, Joins Enavate as CEO $300 Million Initial Investment Commitment Received MENLO PARK, Calif., May 2, 2022 – Patient Square Capital (“Patient Square”), a leading dedicated health care investment firm, today announced the formation of a new portfolio company, Enavate Sciences, to invest in and enable the growth of therapeutic…


Page 2 of 2